1
|
Abbo LM and Hooton TM: Antimicrobial
stewardship and urinary tract infections. Antibiotics (Basel).
3:174–192. 2014.PubMed/NCBI View Article : Google Scholar
|
2
|
Sarshar M, Behzadi P, Ambrosi C, Zagaglia
C, Palamara AT and Scribano D: FimH and Anti-Adhesive therapeutics:
A disarming strategy against uropathogens. Antibiotics (Basel).
9(397)2020.PubMed/NCBI View Article : Google Scholar
|
3
|
Anger J, Lee U, Ackerman AL, Chou R,
Chughtai B, Clemens JQ, Hickling D, Kapoor A, Kenton KS, Kaufman
MR, et al: Recurrent uncomplicated urinary tract infections in
women: AUA/CUA/SUFU guideline. J Urol. 202:282–289. 2019.PubMed/NCBI View Article : Google Scholar
|
4
|
Taich L, Zhao H, Cordero C and Anger JT:
New paradigms in the management of recurrent urinary tract
infections. Curr Opin Urol. 30:833–837. 2020.PubMed/NCBI View Article : Google Scholar
|
5
|
Barea BM, Veeratterapillay R and Harding
C: Nonantibiotic treatments for urinary cystitis: An update. Curr
Opin Urol. 30:845–852. 2020.PubMed/NCBI View Article : Google Scholar
|
6
|
Porru D, Parmigiani A, Tinelli C, Barletta
D, Choussos D, Di Franco C, Bobbi V, Bassi S, Miller O, Gardella B,
et al: Oral D-mannose in recurrent urinary tract infections in
women: A pilot study. J Clin Urol. 7:208–213. 2014.
|
7
|
Vicariotto F: Effectiveness of an
association of a cranberry dried extract, D-mannose and the three
microorganisms Lactobacillus plantarum LP01, Lactobacillus.
paracasei LPC09 in women affected by cystitis: A pilot study. J
Clin Gastroenterol. 48 (Suppl 1):S96–S101. 2014.PubMed/NCBI View Article : Google Scholar
|
8
|
Domenici L, Monti M, Bracchi C, Giorgini
M, Colagiovanni V, Muzii L and Benedetti*Panici P: D-mannose: A
promising support for acute urinary tract infections in women. A
pilot study. Eur Rev Med Pharmacol Sci. 20:2920–2925.
2016.PubMed/NCBI
|
9
|
Marchiori D and Zanello PP: Efficacy of
N-acetylcysteine, D-mannose and morinda citrifolia to treat
recurrent cystitis in breast cancer survivals. In Vivo. 31:931–936.
2017.PubMed/NCBI View Article : Google Scholar
|
10
|
del*Popolo G and Nelli F: Recurrent
bacterial symptomatic cystitis: A pilot study on a new natural
option for treatment. Arch Ital Urol Androl. 90:101–103.
2018.PubMed/NCBI View Article : Google Scholar
|
11
|
Pugliese D, Acampora A, Porreca A, Schips
L and Cindolo L: Effectiveness of a novel oral combination of
D-Mannose, pomegranate extract, prebiotics and probiotics in the
treatment of acute cystitis in women. Arch Ital Urol Androl.
92:34–38. 2020.PubMed/NCBI View Article : Google Scholar
|
12
|
Rădulescu D, David C, Turcu FL, Spătaru
DM, Popescu P and Văcăroiu IA: Combination of cranberry extract and
D-mannose-possible enhancer of uropathogen sensitivity to
antibiotics in acute therapy of urinary tract infections: Results
of a pilot study. Exp Ther Med. 20:3399–3406. 2020.PubMed/NCBI View Article : Google Scholar
|
13
|
Zalewska-Piątek BM and Piątek RJ:
Alternative treatment approaches of urinary tract infections caused
by uropathogenic Escherichia coli strains. Acta Biochim Pol.
66:129–138. 2019.PubMed/NCBI View Article : Google Scholar
|
14
|
Sharma V, Ichikawa M and Freeze HH:
Mannose metabolism: More than meets the eye. Biochem Biophys Res
Commun. 453:220–228. 2014.PubMed/NCBI View Article : Google Scholar
|
15
|
Steinhardt RG, Calvin AD and Dodd EA:
Taste-Structure correlation with alpha-D-Mannose and
beta-D-Mannose. Science. 135:367–368. 1962.PubMed/NCBI View Article : Google Scholar
|
16
|
Hu X, Shi Y, Zhang P, Miao M, Zhang T and
Jiang B: D -Mannose: Properties, production, and applications: An
overview. Compr Rev Food Sci Food Saf. 15:773–785. 2016.PubMed/NCBI View Article : Google Scholar
|
17
|
Alton G, Kjaergaard S, Etchison JR, Skovby
F and Freeze HH: Oral ingestion of mannose elevates blood mannose
levels: A first step toward a potential therapy for
carbohydrate-deficient glycoprotein syndrome type I. Biochem Mol
Med. 60:127–133. 1997.PubMed/NCBI View Article : Google Scholar
|
18
|
Scaglione F, Musazzi UM and Minghetti P:
Considerations on D-mannose mechanism of action and consequent
classification of marketed healthcare products. Front Pharmacol.
12(636377)2021.PubMed/NCBI View Article : Google Scholar
|
19
|
Kranjčec B, Papeš D and Altarac S:
D-mannose powder for prophylaxis of recurrent urinary tract
infections in women: A randomized clinical trial. World J Urol.
32:79–84. 2014.PubMed/NCBI View Article : Google Scholar
|
20
|
Klein T, Abgottspon D, Wittwer M, Rabbani
S, Herold J, Jiang X, Kleeb S, Lüthi C, Scharenberg M, Bezençon J,
et al: FimH antagonists for the oral treatment of urinary tract
infections: From design and synthesis to in vitro and in vivo
evaluation. J Med Chem. 53:8627–8641. 2010.PubMed/NCBI View Article : Google Scholar
|
21
|
Scribano D, Sarshar M, Prezioso C,
Lucarelli M, Angeloni A, Zagaglia C, Palamara AT and Ambrosi C:
D-Mannose treatment neither affects uropathogenic Escherichia coli
properties nor induces stable fimH modifications. Molecules.
25(316)2020.PubMed/NCBI View Article : Google Scholar
|
22
|
Lenger SM, Bradley MS, Thomas DA, Bertolet
MH, Lowder JL and Sutcliffe S: D-Mannose vs other agents for
recurrent urinary tract infection prevention in adult women: A
systematic review and meta-analysis. Am J Obstet Gynecol.
223:265.e1–265.e13. 2020.PubMed/NCBI View Article : Google Scholar
|
23
|
de Nunzio C, Bartoletti R, Tubaro A,
Simonato A and Ficarra V: Role of D-mannose in the prevention of
recurrent uncomplicated cystitis: State of the art and future
perspectives. Antibiotics (Basel). 10(373)2021.PubMed/NCBI View Article : Google Scholar
|
24
|
Liberati A, Altman DG, Tetzlaff J, Mulrow
C, Gøtzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J
and Moher D: The PRISMA statement for reporting systematic reviews
and meta-analyses of studies that evaluate health care
interventions: Explanation and elaboration. PLoS Med.
6(e1000100)2009.PubMed/NCBI View Article : Google Scholar
|
25
|
Moher D, Liberati A, Tetzlaff J and Altman
DG: PRISMA Group. Preferred reporting items for systematic reviews
and meta-analyses: The PRISMA statement. PLoS Med.
6(e1000097)2009.PubMed/NCBI View Article : Google Scholar
|
26
|
Wells GA, Shea B, O'Connell D, Peterson J,
Welch VL, et al: Newcastle-Ottawa Scale for assessing the quality
of nonrandomized studies in Meta-analysis. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp,
2019.
|
27
|
Sterne JAC, Savović J, Page MJ, Elbers RG,
Blencowe NS, Boutron I, Cates CJ, Cheng HY, Corbett MS, Eldridge
SM, et al: RoB 2: A revised tool for assessing risk of bias in
randomised trials. BMJ. 366(l4898)2019.PubMed/NCBI View Article : Google Scholar
|
28
|
Kuzmenko AV, Kuzmenko VV and Gyaurgiev TA:
Use of D-mannose in the prevention of recurrent lower urinary tract
infection in women. Urologiia. 3:128–132. 2020.PubMed/NCBI(In Russian).
|
29
|
Salinas-Casado J, Méndez-Rubio S,
Esteban-Fuertes M, Gómez-Rodríguez A, Vírseda-Chamorro M,
Luján-Galán M, Iglesias-García C and Rituman G: Large study (283
women) on the effectiveness of Manosar®: 2 g of
d-mannose + 140 mg of proanthocyanidins (PAC), of prolonged
release. Arch Esp Urol. 73:491–498. 2020.PubMed/NCBI(In English, Spanish).
|
30
|
Altarac S and Papeš D: Use of D-mannose in
prophylaxis of recurrent urinary tract infections (UTIs) in women.
BJU Int. 113:9–10. 2014.PubMed/NCBI View Article : Google Scholar
|
31
|
Lopes De Carvalho L, Francavilla G, Motta
R and Brichetto G: D-mannose, cranberry and Vitamin C are effective
in preventing urinary tract infections in multiple sclerosis
subjects. Mult Scler. 18:2012.
|
32
|
Efros M, Bromberg W, Cossu L, Nakeleski E
and Katz AE: Novel concentrated cranberry liquid blend, UTI-STAT
with proantinox, might help prevent recurrent urinary tract
infections in women. Urology. 76:841–845. 2010.PubMed/NCBI View Article : Google Scholar
|
33
|
Genovese C, Davinelli S, Mangano K,
Tempera G, Nicolosi D, Corsello S, Vergalito F, Tartaglia E,
Scapagnini G and Di*Marco R: Effects of a new combination of plant
extracts plus d-mannose for the management of uncomplicated
recurrent urinary tract infections. J Chemother. 30:107–114.
2018.PubMed/NCBI View Article : Google Scholar
|
34
|
Madhavan K, Rustagi S, Jena R, Singh UP,
Ansari MS, Srivastava A, Kapoor R and Sureka SK: A prospective
randomized study to define the role of low dose continuous
prophylactic antibiotics and anti-adherence agents in altering the
microbial colonization related to indwelling double-J stents. Asian
J Urol. 8:269–274. 2021.PubMed/NCBI View Article : Google Scholar
|
35
|
Milandri R, Maltagliati M, Bocchialini T,
Del Prete C, Bianchi G, Rocco BM and Micali S: Effectiveness of
D-mannose, Hibiscus sabdariffa and Lactobacillus plantarum therapy
in prevention of infectious events following urodynamic study.
Urologia. 86:122–125. 2019.PubMed/NCBI View Article : Google Scholar
|
36
|
Murina F, Vicariotto F and Lubrano C:
Efficacy of an orally administered combination of Lactobacillus
paracasei LC11, cranberry and D-mannose for the prevention of
uncomplicated, recurrent urinary tract infections in women.
Urologia. 88:64–68. 2021.PubMed/NCBI View Article : Google Scholar
|
37
|
Palleschi G, Carbone A, Zanello PP, Mele
R, Leto A, Fuschi A, Al Salhi Y, Velotti G, Al Rawashdah S, Coppola
G, et al: Prospective study to compare antibiosis versus the
association of N-acetylcysteine, D-mannose and Morinda citrifolia
fruit extract in preventing urinary tract infections in patients
submitted to urodynamic investigation. Arch Ital Urol Androl.
89:45–50. 2017.PubMed/NCBI View Article : Google Scholar
|
38
|
Russo E, Montt Guevara M, Giannini A,
Mannella P, Palla G, Caretto M, Pancetti F, Genazzani AD and
Simoncini T: Cranberry, D-mannose and anti-inflammatory agents
prevent lower urinary tract symptoms in women undergoing prolapse
surgery. Climacteric. 23:201–205. 2020.PubMed/NCBI View Article : Google Scholar
|
39
|
Phé V, Pakzad M, Haslam C, Gonzales G,
Curtis C, Porter B, Chataway J and Panicker JN: Open label
feasibility study evaluating D-mannose combined with home-based
monitoring of suspected urinary tract infections in patients with
multiple sclerosis. Neurourol Urodyn. 36:1770–1775. 2017.PubMed/NCBI View Article : Google Scholar
|
40
|
Mainini G, Passaro M, Schiattarella A,
Franciscis P, Donna MCD and Trezza G: Prevention and treatment of
cystitis during menopause: Efficacy of a nutraceutical containing
D-mannose, inulin, cranberry, bearberry, Olea europaea, Orthosiphon
and Lactobacillus acidophilus. Prz Menopauzalny. 19:130–134.
2020.PubMed/NCBI View Article : Google Scholar
|
41
|
Clayson D, Wild D, Doll H, Keating K and
Gondek K: Validation of a patient-administered questionnaire to
measure the severity and bothersomeness of lower urinary tract
symptoms in uncomplicated urinary tract infection (UTI): The UTI
symptom assessment questionnaire. BJU Int. 96:350–359.
2005.PubMed/NCBI View Article : Google Scholar
|
42
|
Alidjanov JF, Abdufattaev UA, Makhsudov
SA, Pilatz A, Akilov FA, Naber KG and Wagenlehner FM: New
self-reporting questionnaire to assess urinary tract infections and
differential diagnosis: Acute cystitis symptom score. Urol Int.
92:230–236. 2014.PubMed/NCBI View Article : Google Scholar
|
43
|
Alidjanov JF, Naber KG, Abdufattaev UA,
Pilatz A and Wagenlehner FM: Reliability of symptom-based diagnosis
of uncomplicated cystitis. Urol Int. 102:83–95. 2019.PubMed/NCBI View Article : Google Scholar
|
44
|
Grégoire G, Derderian F and Le*Lorier J:
Selecting the language of the publications included in a
meta-analysis: Is there a tower of babel bias? J Clin Epidemiol.
48:159–163. 1995.PubMed/NCBI View Article : Google Scholar
|
45
|
Bouckaert J, Berglund J, Schembri M, De
Genst E, Cools L, Wuhrer M, Hung CS, Pinkner J, Slättegård R,
Zavialov A, et al: Receptor binding studies disclose a novel class
of high-affinity inhibitors of the Escherichia coli FimH adhesin.
Mol Microbiol. 55:441–455. 2005.PubMed/NCBI View Article : Google Scholar
|
46
|
Zhang M, Wang G, Lai F and Wu H:
Structural characterization and immunomodulatory activity of a
novel polysaccharide from lepidium meyenii. J Agric Food Chem.
64:1921–1931. 2016.PubMed/NCBI View Article : Google Scholar
|